VIP patients can be a headache for their doctors

The medical drama playing out daily since President Donald Trump contracted COVID-19 is alarming—but not surprising. Any physician who's ever rendered medical advice or hospital care to a prominent person probably empathizes ...


New drug shows promise in preventing severe COVID

A single infusion of an experimental drug dramatically lowers levels of coronavirus in the bodies of newly infected patients and cuts their chances of hospitalization, the drug's maker reported Wednesday.

Medical economics

German vaccine maker CureVac surges almost 250% in Nasdaq debut

Shares of German biotech company CureVac, which is developing a leading coronavirus vaccine candidate, rocketed Friday in its first day of trading in New York after raising more than $200 million in an initial public offering.

page 1 from 5